These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 23026890)

  • 1. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.
    Mostert B; Sieuwerts AM; Martens JW; Sleijfer S
    Expert Rev Mol Diagn; 2011 Apr; 11(3):259-75. PubMed ID: 21463236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.
    Zeng L; Cui J; Wu H; Lu Q
    Autoimmunity; 2014 Nov; 47(7):419-29. PubMed ID: 24953646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs as molecular biomarkers of cancer.
    Fabbri M
    Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as Promising Tumor Biomarkers.
    Chen M; Calin GA; Meng QH
    Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micromarkers: miRNAs in cancer diagnosis and prognosis.
    Ferracin M; Veronese A; Negrini M
    Expert Rev Mol Diagn; 2010 Apr; 10(3):297-308. PubMed ID: 20370587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.
    Iborra M; Bernuzzi F; Invernizzi P; Danese S
    Autoimmun Rev; 2012 Mar; 11(5):305-14. PubMed ID: 20627134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MicroRNAs in diagnosis and prognosis in lung cancer].
    Avila-Moreno F; Urrea F; Ortiz-Quintero B
    Rev Invest Clin; 2011; 63(5):516-35. PubMed ID: 22468482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
    Borel F; Konstantinova P; Jansen PL
    J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S; Columbano A
    Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
    Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
    Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.